|
gptkbp:instanceOf
|
Antitoxin
|
|
gptkbp:administeredBy
|
Hospital setting
Intravenous injection
|
|
gptkbp:antibodySource
|
Horse (equine)
|
|
gptkbp:approvedBy
|
gptkb:FDA
2013 (HBAT)
|
|
gptkbp:ATCCode
|
gptkb:J06BB01
|
|
gptkbp:compatibleWith
|
Prevention of botulism
|
|
gptkbp:contains
|
Equine-derived antibodies
|
|
gptkbp:containsSerotype
|
G
A
B
C
D
E
F
|
|
gptkbp:contraindication
|
Hypersensitivity to horse proteins
|
|
gptkbp:developedBy
|
gptkb:US_Centers_for_Disease_Control_and_Prevention
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Botulism Antitoxin
|
|
gptkbp:indication
|
Foodborne botulism
Infant botulism (with specific formulation)
Wound botulism
|
|
gptkbp:marketedAs
|
gptkb:Heptavalent_Botulism_Antitoxin_(HBAT)
|
|
gptkbp:mechanismOfAction
|
Neutralizes circulating botulinum toxin
|
|
gptkbp:notEffectiveAgainst
|
Toxin already bound to nerve endings
|
|
gptkbp:pregnancyCategory
|
C (risk cannot be ruled out)
|
|
gptkbp:sideEffect
|
Allergic reaction
Anaphylaxis
Serum sickness
|
|
gptkbp:storage
|
Refrigerated
|
|
gptkbp:target
|
gptkb:Botulinum_toxin
|
|
gptkbp:usedFor
|
Treatment of botulism
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
Yes
|
|
gptkbp:bfsParent
|
gptkb:Cangene_Corporation
|
|
gptkbp:bfsLayer
|
6
|